Biora Therapeutics Operating Income

Biora Therapeutics (BIOR) currently reports a operating income of $-61M as of September 2024. That compares with $-68M in the prior-year period — up 9.9% year over year. Use the charts on this page to explore Biora Therapeutics's operating income history and peer comparisons.

Biora Therapeutics's operating income increased from $-68M to $-61M — a 9.9% year-over-year increase (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biora Therapeutics reported $-61M in operating income as of September 2024. That compares with $-68M in the prior-year period — up 9.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-61M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biora Therapeutics, and consider following BIOR for alerts when major investors trade the stock.

Biora Therapeutics is classified in the Healthcare sector. On operating income, it currently shows $-61M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BIOR with unrelated industries.